One should factor competition into long terms plans for trading this stock. But one when thinking about this one should remember that IBIS world estimates that the data centre specific segment will grow at around 16.8% per year for the foreseeable future - so there is plenty of room for growth even with competition
and the fact is their growth is currently outstanding - they were not 3rd on BRW fast 100 list this year for nothing!
Their current year revenue is up 85% from 2014. New sales up 362% from 2014
we will be seeing net profit in 2016
Right now their price to book value is only 2.18 times. 7 times wouldnt be unreasonable given their assets and growth trajectory (this would mean more than double current share price)
Hence right now is an excellent time to invest in these bad babies.
Savvy investors know this and thats why now is completely different from a year ago.
- Forums
- ASX - By Stock
- Worthy of accumulation
NXT
nextdc limited
Add to My Watchlist
1.05%
!
$14.19

One should factor competition into long terms plans for trading...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.19 |
Change
-0.150(1.05%) |
Mkt cap ! $9.087B |
Open | High | Low | Value | Volume |
$14.51 | $14.63 | $14.17 | $35.40M | 2.482M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 32553 | $14.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.28 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 420 | 14.160 |
5 | 2064 | 14.100 |
1 | 2000 | 14.030 |
1 | 2000 | 14.020 |
2 | 284 | 14.010 |
Price($) | Vol. | No. |
---|---|---|
14.450 | 200 | 1 |
14.590 | 1000 | 1 |
14.600 | 500 | 1 |
14.640 | 500 | 1 |
14.690 | 687 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online